Resolute Integrity Zotarolimus-Eluting Coronary Stent Systems
FDA premarket approval P110013/S095 · decided 2019-10-17
Approval details
- PMA number
- P110013
- Supplement
- S095
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Resolute Integrity Zotarolimus-Eluting Coronary Stent Systems
- Generic name
- Coronary drug-eluting stent
- Applicant
- Medtronic Vascular
- Date received
- 2019-04-17
- Decision date
- 2019-10-17
- Days to decision
- 183 days
- Decision code
- APPR
- Product code
- NIQ
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Santa Rosa, CA
- Statement
- Approval to automated the stent pre-clean manufacturing processes for the Resolute Integrity and Resolute Onyx Drug Eluting Stents.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.